Diabetic neuropathy

This PrimeView highlights the risk factors for diabetic neuropathy, which is the most prevalent complication of diabetes mellitus.

• Publication year

  2019

• Venue

  Nature Reviews Disease Primers

• Publication date

  2019-06-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41572-019-0097-9PMID 31197183PMCID PMC7096070
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Associations between metformin use and vitamin B12 levels, anemia, and neuropathy in patients with diabetes: a meta‐analysis

  2019cited by this paper
• Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

  2018cited by this paper
• Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy

  2018cited by this paper
• Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

  2018cited by this paper
• Diabetes and obesity are the main metabolic drivers of peripheral neuropathy

  2018cited by this paper
• Susceptible and Prognostic Genetic Factors Associated with Diabetic Peripheral Neuropathy: A Comprehensive Literature Review

  2018cited by this paper
• Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons

  2018cited by this paper
• Improvement in Neuropathy Outcomes With Normalizing HbA1c in Patients With Type 2 Diabetes

  2018cited by this paper
• A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy

  2018cited by this paper
• Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians

  2018cited by this paper
• Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016

  2018cited by this paper
• Neuropathic pain drives anxiety behavior in mice, results consistent with anxiety levels in diabetic neuropathy patients

  2018cited by this paper
• Literacy-Adapted Cognitive Behavioral Therapy Versus Education for Chronic Pain at Low-Income Clinics

  2018cited by this paper
• Risk Factors for Incident Diabetic Polyneuropathy in a Cohort With Screen-Detected Type 2 Diabetes Followed for 13 Years: ADDITION-Denmark

  2018cited by this paper
• Conserved Transcriptional Signatures in Human and Murine Diabetic Peripheral Neuropathy

  2018cited by this paper
• Neuropathy.

  2018cited by this paper
• Behavioural, morphological and electrophysiological assessment of the effects of type 2 diabetes mellitus on large and small nerve fibres in Zucker diabetic fatty, Zucker lean and Wistar rats

  2018cited by this paper
• Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study.

  2017cited by this paper
• Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013

  2017cited by this paper
• New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain.

  2017cited by this paper
• Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life

  2017cited by this paper
• Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy

  2017cited by this paper
• Diabetic polyneuropathy, sensory neurons, nuclear structure and spliceosome alterations: a role for CWC22

  2017cited by this paper
• Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.

  2017cited by this paper
• Effect of omega-3 supplementation on neuropathy in type 1 diabetes

  2017cited by this paper
• Regulation and dysregulation of axon infrastructure by myelinating glia

  2017cited by this paper
• NaV channel variants in patients with painful and nonpainful peripheral neuropathy

  2017cited by this paper
• Type 2 diabetes and quality of life

  2017cited by this paper
• Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy

  2017cited by this paper
• Modulation of diet‐induced mechanical allodynia by metabolic parameters and inflammation

  2017cited by this paper
• Sensory phenotype and risk factors for painful diabetic neuropathy: a cross-sectional observational study

  2017cited by this paper
• Discovering early diabetic neuropathy from epidermal nerve fiber patterns

  2016cited by this paper
• Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study

  2016cited by this paper
• Long-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical Trial

  2016cited by this paper
• Recent advances in exploring the genetic susceptibility to diabetic neuropathy.

  2016cited by this paper
• Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns

  2016cited by this paper
• Early recognition of diabetic peripheral neuropathy and the need for one-stop microvascular assessment.

  2016cited by this paper
• Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population.

  2016cited by this paper
• CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

  2016cited by this paper
• Risk factors for neuropathic pain in diabetes mellitus

  2016cited by this paper
• Altered potassium channel distribution and composition in myelinated axons suppresses hyperexcitability following injury

  2016cited by this paper
• Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status

  2016cited by this paper
• Prediction of protective sensory loss, neuropathy and foot ulceration in type 2 diabetes

  2016cited by this paper
• The Pain in Neuropathy Study (PiNS): a cross-sectional observational study determining the somatosensory phenotype of painful and painless diabetic neuropathy

  2016cited by this paper
• 10. Microvascular Complications and Foot Care

  2016cited by this paper
• Diabetic Neuropathy: A Position Statement by the American Diabetes Association

  2016cited by this paper
• Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes

  2015cited by this paper
• Incidence of polyneuropathy in Utrecht, the Netherlands

  2015cited by this paper
• Safety and efficacy of ranirestat in patients with mild‐to‐moderate diabetic sensorimotor polyneuropathy

  2015cited by this paper
• SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity

  2015cited by this paper
• Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature.

  2015cited by this paper
• Treatment of painful diabetic neuropathy

  2015cited by this paper
• Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients

  2015cited by this paper
• Mechanisms of distal axonal degeneration in peripheral neuropathies.

  2015cited by this paper
• Diabetic neuropathic pain: Physiopathology and treatment.

  2015influential reference
• Circuitry and plasticity of the dorsal horn--toward a better understanding of neuropathic pain.

  2015cited by this paper
• LDIflare small fiber function in normal glucose tolerant subjects with and without hypertriglyceridemia

  2015cited by this paper
• The role of serum methylglyoxal on diabetic peripheral and cardiovascular autonomic neuropathy: the ADDITION Denmark study

  2015cited by this paper
• VibraTip™ for Testing Vibration Perception to Detect Diabetic Peripheral Neuropathy: A NICE Medical Technology Guidance

  2015cited by this paper
• Nortriptyline for neuropathic pain in adults.

  2015cited by this paper
• A randomized double-blind, placebo-, and active-controlled study of T-type calcium channel blocker ABT-639 in patients with diabetic peripheral neuropathic pain

  2015cited by this paper
• Modulating Molecular Chaperones Improves Mitochondrial Bioenergetics and Decreases the Inflammatory Transcriptome in Diabetic Sensory Neurons.

  2015cited by this paper
• Longitudinal patient-oriented outcomes in neuropathy

  2015cited by this paper
• Evidence for Epigenetic Regulation of Gene Expression and Function in Chronic Experimental Diabetic Neuropathy

  2015cited by this paper
• Distal Sensorimotor Neuropathy: Improvements in Diagnosis.

  2015cited by this paper
• Mitochondrial Dysfunction in Diabetic Neuropathy: a Series of Unfortunate Metabolic Events

  2015cited by this paper
• Burning through the pain: treatments for diabetic neuropathy

  2015influential reference
• The Metabolic Syndrome and Microvascular Complications in a Murine Model of Type 2 Diabetes

  2015cited by this paper
• Does the emptier have no clothes? Diabetes, gastric emptying, and the syndrome of gastroparesis.

  2015cited by this paper
• The Importance of Rare Subtypes in Diagnosis and Treatment of Peripheral Neuropathy: A Review.

  2015cited by this paper
• Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.

  2015cited by this paper
• Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis.

  2015cited by this paper
• Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience.

  2015cited by this paper
• Pharmacological treatment of diabetic peripheral neuropathy.

  2015influential reference
• Distal Symmetric Polyneuropathy: A Review.

  2015cited by this paper
• Does the Prevailing Hypothesis That Small-Fiber Dysfunction Precedes Large-Fiber Dysfunction Apply to Type 1 Diabetic Patients?

  2014cited by this paper
• Prevalence and clinical implications of painful diabetic peripheral neuropathy in type 2 diabetes: results from a nationwide hospital-based study of diabetic neuropathy in Korea.

  2014cited by this paper
• A Pooled Analysis Evaluating the Efficacy and Tolerability of Tapentadol Extended Release for Chronic, Painful Diabetic Peripheral Neuropathy

  2014cited by this paper
• Painful Diabetic Neuropathy: Many Similarly Effective Therapies With Widely Dissimilar Costs

  2014cited by this paper
• Painful and painless channelopathies.

  2014cited by this paper
• Magnetic Resonance Neuroimaging Study of Brain Structural Differences in Diabetic Peripheral Neuropathy

  2014cited by this paper
• Advanced Glycation End Products and Diabetic Complications

  2014cited by this paper
• Corneal Confocal Microscopy Shows an Improvement in Small-Fiber Neuropathy in Subjects With Type 1 Diabetes on Continuous Subcutaneous Insulin Infusion Compared With Multiple Daily Injection

  2014cited by this paper
• Exercise increases cutaneous nerve density in diabetic patients without neuropathy

  2014cited by this paper
• A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

  2014cited by this paper
• Sublime microglia: expanding roles for the guardians of the CNS.

  2014cited by this paper
• Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes.

  2014cited by this paper
• Role of neurologists and diagnostic tests on the management of distal symmetric polyneuropathy.

  2014cited by this paper
• Painful diabetic neuropathy

  2014cited by this paper
• Diabetic autonomic neuropathy.

  2014cited by this paper
• Pharmacologic Interventions for Painful Diabetic Neuropathy

  2014cited by this paper
• Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy

  2014cited by this paper
• The contributors of emotional distress in painful diabetic neuropathy

  2014cited by this paper
• Why are there no good treatments for diabetic neuropathy?

  2014cited by this paper
• Association between visceral, cardiac and sensorimotor polyneuropathies in diabetes mellitus.

  2014cited by this paper
• Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials

  2014cited by this paper
• Early Detection of Nerve Fiber Loss by Corneal Confocal Microscopy and Skin Biopsy in Recently Diagnosed Type 2 Diabetes

  2014cited by this paper
• Benefits of exercise intervention in reducing neuropathic pain

  2014cited by this paper
• Recognition and management of psychosocial issues in diabetic neuropathy.

  2014cited by this paper
• Mechanisms of disease: Mitochondrial dysfunction in sensory neuropathy and other complications in diabetes.

  2014cited by this paper

• Innovative Diabetes Therapies and Impact on Peripheral and Autonomic Diabetic Neuropathies: A State-of-the-Art Review.

  2026cites this paper
• Therapeutic and Diagnostic Landscape of Diabetic Neuropathy: A Systematic Review of Clinical Studies.

  2026cites this paper
• Nerve ultrasound in painful diabetic neuropathy: a pilot study of sural and tibial nerves

  2026cites this paper
• Prediction of diabetic peripheral neuropathy in type 2 diabetes using high-frequency ultrasound and shear-wave elastography of the median and tibial nerves: a nomogram study

  2026cites this paper
• Nervonic acid confers neuroprotection in a zebrafish model of diabetic neuropathy by promoting myelin repair and metabolic modulation.

  2026cites this paper
• A structural overview of G-protein-coupled receptors in neurological disorders.

  2026cites this paper
• Immunological mechanisms and therapeutic advances in diabetic neuropathy

  2026cites this paper
• Mechanistic insights into the role of salicin in mitigating oxidative and inflammatory pathways of diabetic complications

  2026cites this paper
• Prevalence and impact of fibromyalgia on patients with type 2 diabetes: a large-scale real-world data analysis.

  2026cites this paper
• Topical frankincense treatment on relieving high-risk diabetic foot in rats by reducing inflammation and improving microcirculation

  2025cites this paper
• Cell and molecular profiles in peripheral nerves shift toward inflammatory phenotypes in diabetic peripheral neuropathy

  2025cites this paper
• Spiroketal natural products isolated from traditional Chinese medicine: isolation, biological activity, biosynthesis, and synthesis.

  2025cites this paper
• Engineered miR-214 enriched Schwann cell-derived extracellular vesicles amplify therapeutic efficacy for peripheral neuropathy in T2D mice

  2025cites this paper
• Gene editing strategies to address current challenges in stem cell-derived β cell therapy for type 1 Diabetes

  2025cites this paper
• Astrogliopathology: A core pathogenic factor in diabetic neuropathic pain

  2025cites this paper
• Machine learning in the prediction of diabetic peripheral neuropathy: a systematic review

  2025cites this paper
• Automated pancreatic extracellular volume fraction as a biomarker for microangiopathy in type 2 diabetes mellitus

  2025cites this paper
• MOTS-c mimics exercise to combat diabetic liver fibrosis by targeting Keap1-Nrf2-Smad2/3

  2025cites this paper
• Neurovascular and cognitive damages of diabetes mellitus to the central nervous system

  2025cites this paper
• Diagnostic advancements in early detection of diabetic neuropathy: comparative analysis of medial and lateral plantar nerve degeneration

  2025cites this paper
• Impact of type 1 diabetes on binocular vision: Evidence from a comparative analysis

  2025cites this paper
• Comparison of inflammatory markers and nerve conduction studies in prediabetes and type two diabetes mellitus: A possible role in neuropathy

  2025cites this paper
• Systemic Immune-Inflammation Index (SII) of Patients With and Without Diabetic Neuropathy: A Cross-Sectional Study

  2025cites this paper
• Acupuncture for cognitive impairment in type 2 diabetes mellitus: a systematic review and Bayesian network meta-analysis protocol

  2025cites this paper
• Klotho: A possible diagnostic biomarker and therapeutic target in diabetes complications

  2025cites this paper
• Long-lasting and fast methylglyoxal-scavenging peptide CycK(Myr)R4E alleviates chronic pain in type 2 diabetic mice

  2025cites this paper
• J-Shaped Relationship Between Visceral Fat Area and Large-Nerve Fiber Dysfunction Estimated by Vibration Perception Threshold in Type 2 Diabetes: A Cross-Sectional Study

  2025cites this paper
• Pathologic and Therapeutic Schwann Cells

  2025cites this paper
• Birth weight and prematurity for predicting type 2 diabetes mellitus: a prognostic review

  2025cites this paper
• Role of mitochondrial dysfunction in ocular surface diseases

  2025cites this paper
• The association between urinary and dietary potassium and diabetic microvascular complications: insights from UK Biobank data

  2025cites this paper
• Interventional effects of exercise on neuropathy in patients with diabetes: a systematic review with meta-analysis

  2025cites this paper
• Inhibition of LINC00707/miR‐223‐3p/FKBP5 axis has a protective effect on diabetic kidney disease

  2025cites this paper
• A Retrospective Assessment of Neuropathic Pain in Response to Intraneural Facilitation® Therapy and Neurovascular Index-Guided Food Elimination

  2025cites this paper
• Impact of Selective Peroxisome Proliferator-Activated Receptor (PPAR)-α Modulators and Fibrates on Microvascular Disease: Is There Still Room?

  2025cites this paper
• A real-world multicenter cross-sectional observational study to assess the clinical profile of peripheral neuropathy in patients with diabetes

  2025cites this paper
• Early diagnosis and risk factors of diabetic peripheral neuropathy in type 1 diabetes: insights from current perception threshold testing

  2025cites this paper
• Flavonoids regulating NLRP3 inflammasome: a promising approach in alleviating diabetic peripheral neuropathy

  2025cites this paper
• Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse model.

  2025cites this paper
• Deciphering diabetic neuropathy: immune cell causality revealed

  2025cites this paper
• Melatonin Alleviates Oxidative Stress‐Induced Mitochondrial Dysfunction Through Ameliorating NAD+ Homeostasis of hDPSCs for Cell‐Based Therapy

  2025cites this paper
• Evaluating Muscular and Cardiovascular Responses to Isometric Handgrip Exercise Among Diabetics and Non-diabetics in a Tertiary Care Center

  2025cites this paper
• Genetics of diabetes and its complications: a comprehensive review

  2025cites this paper
• Peripheral neuropathic and renal complications in patients with diabetes mellitus 2

  2025cites this paper
• The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review

  2025cites this paper
• SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosis.

  2025cites this paper
• Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations.

  2025cites this paper
• Tang Bi formula alleviates diabetic sciatic neuropathy via AMPK/PGC-1α/MFN2 pathway activation

  2025cites this paper
• Transcranial magnetic stimulation measures of corticospinal excitability in Black and Hispanic/Latino people with painful peripheral neuropathy

  2025cites this paper
• Strengthening monocarboxylate transporters by adiponectin receptor agonist ameliorates diabetic peripheral neuropathy

  2025cites this paper
• Intranasal Administration of the Combination of Dextro-Ketamine and Dexmedetomidine for Treatment of Diabetic Neuropathic Pain in Rats

  2025cites this paper
• Diabetes distress and sleep impairment in type 2 diabetes: A population‐based cross‐sectional study—The HUNT Study, Norway

  2025cites this paper
• Comparative study on the analgesic effect of vortioxetine and other antidepressants in the streptozotocin mouse model of painful diabetic neuropathy

  2025cites this paper
• Burdens of sense organ diseases across global, regional, and national levels from 1990 to 2021 and projections for 2050

  2025cites this paper
• Disruption of intestinal barrier and dysbiosis of gut microbiota in an experimental rhesus macaque model with 6-year diabetes mellitus

  2025cites this paper
• A nomogram for predicting bladder dysfunction in patients with type 2 diabetes mellitus: a retrospective study

  2025cites this paper
• Targeted neural stem cell-derived extracellular vesicles loaded with Sinomenine alleviate diabetic peripheral neuropathy via WNT5a/TRPV1 pathway modulation

  2025cites this paper
• Mitochondrial quality control in diabetes mellitus and complications: molecular mechanisms and therapeutic strategies

  2025cites this paper
• Investigation of the protective effects of dichloroacetic acid in a rat model of diabetic neuropathy

  2025cites this paper
• Diabetic Neuropathy Part 1: Overview and Symmetric Phenotypes.

  2025cites this paper
• Causal relationships between plasma lipidome and diabetic neuropathy: a Mendelian randomization study

  2025cites this paper
• Red cell distribution width (RDW), RDW to albumin ratio (RAR), and long‐term mortality in diabetic neuropathy: A NHANES analysis, 1999–2019

  2025cites this paper
• Self-care and health-related quality of life in Mexican older adults with type 2 diabetes

  2025cites this paper
• N-acetyl-L-cysteine mitigates diabetes-induced impairments in sciatic nerve

  2025cites this paper
• Correlation between Sirtuin 1 downregulation and reduced vitamin D receptor expression in patients with diabetic neuropathy

  2025cites this paper
• Are Inflammatory Markers Important for Assessing the Severity of Diabetic Polyneuropathy?

  2025cites this paper
• Levels of DEFA1, Progranulin, and NRG4 in Patients with Autonomic Neuropathy: Potential Biomarkers for Diagnosis and Prognosis

  2025cites this paper
• PEX11B palmitoylation couples peroxisomal dysfunction with Schwann cells fail in diabetic neuropathy

  2025cites this paper
• Association of PTX3 Genetic Variants With Development of Diabetic Neuropathy

  2025cites this paper
• Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic

  2025cites this paper
• BuZhong YiQi Formula Alleviates Diabetes-Caused Hyposalivation by Activating Salivary Secretion Pathway in the Parotid and Submandibular Glands of Rats

  2025cites this paper
• Loss and damage in large-diameter sensory neurons in the db/db diabetic mouse

  2025cites this paper
• Transferosome-Enhanced Transdermal Therapy: A Novel Approach for Duloxetine Delivery for Management of Neuropathic Pain

  2025cites this paper
• Glabridin as a selective Kv2.1 inhibitor ameliorates DPN pathology by disrupting the Aβ/Kv2.1/JNK/NF-κB/NLRP3/p-Tau pathway

  2025cites this paper
• Defective PINK1-dependent mitophagy is involved in high glucose-induced neurotoxicity.

  2025cites this paper
• Prognostic nutritional index and diabetic peripheral neuropathy in type 2 diabetes: a machine learning approach

  2025cites this paper
• Reduced heart rate response to exercise in patients with type 2 diabetes

  2025cites this paper
• Genomic correlation, shared loci, and causal link between obesity and diabetic microvascular complications: A genome-wide pleiotropic analysis

  2025cites this paper
• Impact of Neuropathy on Well-Being and Health-Related Quality of Life in Adolescents With Type 1 Diabetes

  2025cites this paper
• Diabetic neuropathy: cutting-edge research and future directions

  2025influential citation
• Artificial Intelligence Algorithm to Screen for Diabetic Neuropathy: A Pilot Study

  2025cites this paper
• Changes of intestinal microbiome and its relationship with painful diabetic neuropathy in rats

  2025cites this paper
• Neural Organoids Protect Engineered Heart Tissues From Glucolipotoxicity by Transferring Versican in a Co‐Culture System

  2025cites this paper
• Comparison and evaluation of negative pressure wound therapy versus standard wound care in the treatment of diabetic foot ulcers

  2025cites this paper
• Association of peripheral neuropathy with dementia in type 2 diabetes: a 5-year follow-up study using the national health insurance service-national health information database

  2025cites this paper
• Acupoint injection increases the efficacy of vitamin B12 for diabetic neuropathy: a meta-analysis and trial sequential analysis

  2025cites this paper
• Empowering Pharmacists in Type 2 Diabetes Care: Opportunities for Prevention, Counseling, and Therapeutic Optimization

  2025cites this paper
• Hormonal influences on thermotactile threshold, pain perception threshold and tolerance: A digital thermoaesthesiometer study

  2025cites this paper
• Combination of Rare Sugars L-arabinose, D-mannose, D-xylose, D-allulose, and D-tagatose Alleviates Cognitive Impairment in Mice with Type 2 Diabetes Mellitus

  2025cites this paper
• Associations Between Renal Dysfunction Subtypes and Vertebral Fracture in Patients with Type 2 Diabetes: A Longitudinal Study

  2025cites this paper
• High‐Fat Diet Disrupt Nerve Function by Targeting Schwann Cells

  2025cites this paper
• Sleep deprivation in third-trimester pregnancies is multi-causal and requires careful differential consideration

  2025cites this paper
• Hand-Related Activities of Daily Living Challenges Among Individuals With Diabetic Peripheral Neuropathy: A Scoping Review

  2025cites this paper
• Prevalence and Presentation of Lower Limb Neurovascular Complications in Children With Diabetes: A Systematic Review With Proportion Meta-Analysis

  2025cites this paper
• SP1 activates AKT3 to facilitate the development of diabetic nephropathy

  2025cites this paper
• Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy

  2025cites this paper
• Clinical Phenotypes of Diabetic Peripheral Neuropathy: Implications for Phenotypic-Based Therapeutics Strategies

  2025cites this paper
• Impact of diabetes mellitus on spinal injection two-week outcomes in patients with predominant lower extremity pain

  2025cites this paper
• TangBi Formula for Painful Diabetic Distal Symmetric Polyneuropathy: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled and Parallel‐Group Trial

  2025cites this paper
• Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study

  2025cites this paper